[HTML][HTML] Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models

D Lissa, N Takahashi, P Desai, I Manukyan… - Nature …, 2022 - nature.com
Molecular subtypes of small cell lung cancer (SCLC) defined by the expression of key
transcription regulators have recently been proposed in cell lines and limited number of …

[HTML][HTML] MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate

AS Ireland, AM Micinski, DW Kastner, B Guo, SJ Wait… - Cancer cell, 2020 - cell.com
Small cell lung cancer (SCLC) is a neuroendocrine tumor treated clinically as a single
disease with poor outcomes. Distinct SCLC molecular subtypes have been defined based …

Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study

Z Megyesfalvi, N Barany, A Lantos… - The Journal of …, 2022 - Wiley Online Library
The tissue distribution and prognostic relevance of subtype‐specific proteins (ASCL1,
NEUROD1, POU2F3, YAP1) present an evolving area of research in small‐cell lung cancer …

A biobank of small cell lung cancer CDX models elucidates inter-and intratumoral phenotypic heterogeneity

KL Simpson, R Stoney, KK Frese, N Simms, W Rowe… - Nature Cancer, 2020 - nature.com
Although small cell lung cancer (SCLC) is treated as a homogeneous disease, biopsies and
preclinical models reveal heterogeneity in transcriptomes and morphology. SCLC subtypes …

[HTML][HTML] Prognostic implications of molecular subtypes in primary small cell lung cancer and their correlation with cancer immunity

J Qi, J Zhang, N Liu, L Zhao, B Xu - Frontiers in Oncology, 2022 - frontiersin.org
Introduction Small cell lung cancer (SCLC) has recently been characterized as
heterogeneous tumors due to consensus nomenclature for distinct molecular subtypes on …

Small cell lung cancer: Subtypes and therapeutic implications

WZ Wang, A Shulman, JM Amann, DP Carbone… - Seminars in cancer …, 2022 - Elsevier
Small cell lung cancer (SCLC) is an extremely aggressive neuroendocrine tumor,
accounting for approximated 13% of all lung cancer cases. SCLC is characterized by rapid …

[HTML][HTML] New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts

S Lantuejoul, L Fernandez-Cuesta… - … lung cancer research, 2020 - ncbi.nlm.nih.gov
Large cell neuroendocrine carcinoma (LCNECs) and small cell lung carcinomas (SCLCs)
are high-grade neuroendocrine carcinomas of the lung with very aggressive behavior and …

[HTML][HTML] Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes

W Zhang, L Girard, YA Zhang, T Haruki… - … lung cancer research, 2018 - ncbi.nlm.nih.gov
Background Small cell lung cancer (SCLC) is a deadly, high grade neuroendocrine (NE)
tumor without recognized morphologic heterogeneity. However, over 30 years ago we …

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution

D Dora, C Rivard, H Yu, P Bunn, K Suda… - Molecular …, 2020 - Wiley Online Library
Small cell lung cancer (SCLC) has recently been subcategorized into neuroendocrine (NE)‐
high and NE‐low subtypes showing 'immune desert'and 'immune oasis' phenotypes …

Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation

S Sivakumar, JA Moore, M Montesion, R Sharaf, DI Lin… - Cancer discovery, 2023 - AACR
Small cell lung cancer (SCLC) is a recalcitrant neuroendocrine carcinoma with dismal
survival outcomes. A major barrier in the field has been the relative paucity of human tumors …